Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: Literature review

Journal of Child Neurology

Volumn 14, Issue 2, 1999, Pages 71-74

  Hancock, Eleanor ^a   Osborne, John P ^a  

^a ROYAL UNITED HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIGABATRIN;

ARTICLE; CHILD; COMORBIDITY; DRUG EFFICACY; DRUG SAFETY; ELECTROENCEPHALOGRAPHY; FEMALE; HIGH RISK POPULATION; HUMAN; HYPSARRHYTHMIA; INFANT; INFANTILE SPASM; LEARNING DISORDER; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; PRIORITY JOURNAL; PSYCHOMOTOR RETARDATION; TUBEROUS SCLEROSIS;

EID: 0033016102     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389901400201     Document Type: Article

References (26)

1. Webb DW, Fryer AE, Osborne JP: On the morbidity associated with tuberous sclerosis: A population study. Dev Med Child Neurol 1987; 62:41-44.
2. Bobele GB, Bodensteiner JB: Infantile spasms. Neurol Clin 1990;8: 633-645.
3. Riikonen R: Long-term outcome of West syndrome: A study of adults with a history of infantile spasms. Epilepsia 1996;37:367.
4. Appleton RE, Montiel-Viesca F: Vigabatrin in infantile spasms. Why add on?, letter. Lancet 1993;341:962.
5. Appleton RE: Vigabatrin in the management of generalized seizures in children. Seizure 1995;4:45-48.
6. Appleton RE: A simple, effective and well-tolerated treatment regime for West syndrome. Dev Med Child Neurol 1995;37:185-187.
7. Chiron C, Dulac O, Luna L: Vigabatrin in infantile spasms. Lancet 1990;10:363-364.
8. Vles JSH, van der Heyden AMHG, Ghijs A, Troost J: Vigabatrin in the treatment of infantile spasms. Neuropediatrics 1993;24: 230-231.
9. Schmitt B, Wohlrab G, Boltshauser E: Vigabatrin in newly diagnosed infantile spasms, letter. Neuropediatrics 1994;25:54.
10. Chiron C, Dulac O, Beaumont D, et al: Therapeutic trial of vigabatrin in refractory infantile spasms. J Child Neurol 1991;6(Suppl 2):2552-2559.
11. Vigevano F, Cilio MR, Faberi A, et al: Vigabatrin versus ACTH in the treatment of infantile spasms. Epilepsia 1995;36:s265.
12. Aicardi J and Peer Review Groups, Mumford JP, Dumas C, Wood S: Vigabatrin as initial therapy for infantile spasms; a European retrospective survey. Epilepsia 1996;37:638-642.
13. Chiron C, Dumas C, Jambaque I, et al: Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res 1997;26:389-395.
14. Riikonen R, Donner M: Incidence and etiology of infantile spasms from 1960 to 1976: A population study in Finland. Dev Med Child Neurol 1979;21:333-343.
15. Cowen LD, Hudson LS: The epidemiology and natural history of infantile spasms. J Child Neurol 1991;6:355-364.
16. Ohtsuka O, Amano R, Mizukawa M, et al: Treatment of intractable epilepsy with high dose valproate. Epilepsia 1992;33:158-164.
17. Bachman D: Use of valproic acid in treatment of infantile spasms. Arch Neurol 1982;39:49-52.
18. Siemes H, Spohr HL, Michael TH, Nau H: Therapy of infantile spasms with valproate: Results of a prospective study. Epilepsia 1988;29:553-560.
19. Dreifuss F, Farwell J, Holmes G, et al: Infantile spasms: Comparative trial of nitrazepam and corticotrophin. Arch Neurol 1986;43:1107-1110.
20. Matsumoto FA, Watanabe K, Negoro T, et al: Long-term prognosis after infantile spasms: A statistical study of prognostic factors in 200 cases. Dev Med Child Neurol 1981;23:51-65.
21. Nabbout RC, Chiron C, Mumford J, et al: Vigabatrin in partial seizures in children. J Child Neurol 1997;12:172-177.
22. Grant SM, Heel RC: Vigabatrin: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control. Drugs 1991;41:889-926.
23. Eke T, Talbot JF, Lawden MC: Severe persistent visual field constriction associated with vigabatrin. BMJ 1997;314:180-181.
24. Mackenzie R, Klistorner A: Asymptomatic as well as symptomatic defects occur with vigabatrin, letter. BMJ 1998;316:233.
25. Harding GFA: Severe persistent visual field constriction associated with vigabatrin, letter. BMJ 1998;316:232.
26. Wilson EA, Wong ICK, Blackwell N, et al: Severe persistent visual field constriction associated with vigabatrin, letters. BMJ 1997;314:1693-1695.